Maze Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Maze Therapeutics's estimated annual revenue is currently $30.2M per year.
- Maze Therapeutics's estimated revenue per employee is $193,750
- Maze Therapeutics's total funding is $381M.
Employee Data
- Maze Therapeutics has 156 Employees.
- Maze Therapeutics grew their employee count by 12% last year.
Maze Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP | Reveal Email/Phone |
2 | VP, Technical Operations | Reveal Email/Phone |
3 | Head Pharmacology | Reveal Email/Phone |
4 | VP - Head Biology | Reveal Email/Phone |
5 | VP Clinical Pharmacology and Nonclinical Development | Reveal Email/Phone |
6 | SVP Human Resources | Reveal Email/Phone |
7 | VP, Clinical Science | Reveal Email/Phone |
8 | SVP, Drug Discovery | Reveal Email/Phone |
9 | President Research & Development | Chief Medical Officer | Reveal Email/Phone |
10 | VP, Data Science | Reveal Email/Phone |
Maze Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Maze Therapeutics?
Maze Therapeutics is translating novel genetic insights into lifesaving medicines, through an approach that integrates human genetics and functional genomics. Advances in these areas have enabled us to decode the mysteries of genetic modifiers in a range of severe diseases, which we aim to turn into medicines that mimic protective mutations. We have assembled a world-class team that we need to realize this vision, including creative scientific pioneers in genetics, experienced company builders, and biotech industry leaders.
keywords:N/A
$381M
Total Funding
156
Number of Employees
$30.2M
Revenue (est)
12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Maze Therapeutics News
... no equity) and is on the Clinical Advisory Board (cash and equity) of Maze Therapeutics. No research support is received.
Still, Maze Therapeutics has not put all its eggs in the gene therapy basket, and is also developing large and small molecules against...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mar 23, 2021-- Maze Therapeutics, a company translating genetic insights into new precision medicines, today revealed its first three lead therapeutic candidates in the company’s wholly owned pipeline. The candidates include: An oral therapy target ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mar 23, 2021-- Maze Therapeutics, a company translating genetic insights into new precision medicines, today announced that Atul Dandekar, a successful business leader with nearly 25 years of pharmaceutical industry experience, has joined the Compan ...
Maze Therapeutics, a South San Francisco, CA-based company focused on translating genetic insights into new medicines, received an investment from City Hill Ventures. The amount of the deal was not disclosed. In conjunction with the funding, Jonathan Lim, M.D., founder and managing partner at ...
Other Companies in South San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $10M | 164 | 37% | $207.4M |
#2 | $23.7M | 166 | 11% | $125M |
#3 | $27.4M | 172 | N/A | N/A |
#4 | $33.7M | 174 | -8% | $278.1M |
#5 | $76.7M | 176 | -32% | $420.4M |